Greenwich LifeSciences, Inc.

GLSI Healthcare Biotechnology

In the quarter to June 2026, EPS grew 10.0% and free cash flow grew 13.1%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

14.55 0.77 −5.03%
Market cap
$224.9M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Current Ratio
0.00 0.12 0.00 27.41 70.62 51.23 23.74 1.28 1.06
Net Debt/EBITDA
0.00 0.05 0.00 15.41 5.92 1.68 0.75 0.23 0.32
Debt/Assets
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt/Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating CF/Net income
0.08 0.07 0.09 0.62 0.94 0.79 0.73 0.42 0.51
Capex/Depreciation
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
16.86% 18.11% 59.69% (14.18%) (16.78%) (39.08%) (89.30%) (457.73%) (3,068.35%)
ROA
(2,320.80%) (3,114.65%) (5,067.01%) (12.98%) (16.35%) (38.46%) (86.87%) (314.09%) (376.92%)
ROIC
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
282.29% 262.58% 249.97% (6.75%) (17.04%) (59.26%) (132.81%) (1,920.19%) (5,480.80%)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Intangible Assets out of Total Assets
0.00 0.22 0.74 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
— — 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow per Share
(0.01) (0.01) (0.13) (0.12) (0.33) (0.48) (0.50) (0.56) (0.73)
Cash per Share
0.00 0.01 0.00 3.02 2.10 1.04 0.54 0.31 0.46
Shareholders Equity per Share
(0.73) (0.86) (0.60) 2.91 2.07 1.02 0.52 0.07 0.03
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
(0.73) (0.86) (0.60) 2.91 2.07 1.02 0.52 0.07 0.03
Free Cash Flow
(0.12) (0.11) (0.29) (1.15) (4.29) (6.20) (6.48) (7.27) (9.91)
Working Capital
(0.56) (0.64) (1.37) 27.61 26.82 13.21 6.70 0.91 0.35
Net Current Asset Value
(8.56) (10.14) (1.37) 27.61 26.82 13.21 6.70 0.91 0.35
Other line items
Quick Ratio
0.00 0.12 0.00 27.41 70.62 51.23 23.74 1.28 1.06
Depreciation/Fixed assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash ROIC
1.42% 1.15% 21.83% (2.05%) (7.94%) (23.24%) (47.32%) (145.31%) (151.79%)
Accounts Payable Turnover
0.02 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 — — —
Average Days of Payables
16,333.75 28,145.56 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days of Inventory on Hand
0.00 0.00 0.00 0.00 0.00 0.00 — — —
Revenue per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating CF per Share
(0.01) (0.01) (0.13) (0.12) (0.33) (0.48) (0.50) (0.56) (0.73)
Capex per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Payables
0.22 0.22 0.50 0.72 0.47 0.22 0.24 1.53 3.84
Average Assets
0.07 0.05 0.07 14.35 27.95 20.35 10.24 5.54 5.14
Average Common Equity
(9.33) (9.33) (5.74) 13.14 27.23 20.02 9.96 3.80 0.63

Fold the line items

Columns are period end dates